FIG. 6.
Ontogeny of complement binding antibodies during acute HIV-1 infection in times post-T0. Two representative patients (Pt) from the eclipse phase cohort (6240 and 6246) that had detectable HIV-specific antibodies were assessed for complement activation with an early virus isolate, HIV QH0692, and a laboratory-adapted isolate, HIV SF162.